Welcome to Prospect - a support group for prostate cancer patients, their wives, partners and carers.
Prospect is run by prostate cancer survivors for the benefit of the communities in Bristol and surrounding districts

  • NEXT: Four get-togethers

    A coffee drop-in session will be held from 10am-noon on September 8 in the Macmillan Wellbeing Centre’s Cherry Tree Room, Southmead Hospital – and a new multi-storey car park has opened there. Our next informal meeting is at BAWA, Filton, on September 27 (7pm), with a buffet. Members/partners welcome. On October 7 a 3-mile walk and pub lunch is planned around Lansdown, Bath. Meet at Braithwayt Arms, BA1 9BT, at 10am, returning there for lunch. Want lunch? Email chrismillett@2gmail.com or phone 07721436318.  The speaker at our November 7 meeting, Dr Matthew Lloyd, from the Department Pharmacy and Pharmacology at Bath University, will tell how new cancer treatments are developed.

  • NEWS: Early detection claimed

    Scientists at Israel’s Weizmann Institute might have found a prostate cancer cure, at least if it’s caught in its early stage. See

     

  • Southmead launches appeal

    Southmead Hospital Charity launched an ambitious £2m appeal to fund two new robots to help keep it at the forefront of UK prostate cancer care and help save the lives of even more men in Bristol and the West. More details here on a site where you can see upcoming events, make a payment and download a publicity leaflet. Also see a PDF of PCa Care Appeal Events

  • More accurate predictions?

    Patients might be offered a more accurate prediction of their prostate cancer risk with a novel stratification method developed by Cambridge University researchers. See

  • Biopsies may be ‘out’

    Urologists are committed to rolling out diagnostic use of the new MRI scans once their benefits are officially confirmed. The scans make it possible to rule out the need for a biopsy in many men who don’t have a clinically significant prostate cancer. See. And US researchers have identified a marker of aggressive prostate cancer. See

     

  • Cancer ‘man made’

    Cancer is a man-made disease fuelled by the excesses of modern life, Manchester University researchers reported in July. See

  • Degarelix approved

    In July, NICE recommended degarelix for men with advanced hormone-dependent prostate cancer – those with spinal metastases. See

     

  • New drug ‘promising’

    A new type of drug could benefit men with aggressive prostate cancer that is no longer responding to treatment, Institute of Cancer Research researchers have said. See

  • Funds sought for new test

    Crowdfunding donations are being sought for a new non-invasive and affordable diagnostic test for the early detection of prostate cancer. To find out more and contribute, see

  • Improved PSA test in view

    Birmingham University staff are working on a new test that will improve the PSA one. See

  • Help pages updated

    The Macmillan information section on prostate cancer has been redesigned and is now live. The information has been split into early (localised), locally-advanced and advanced to provide relevant information quickly. See

Running

A friendly and supportive network that aims to:

We have found that knowledge is of great benefit to the patient. It enables him to play an active part in the decision-making process, for example in selecting the best treatment.

We offer a friendly welcome – come and join us

Are you just diagnosed, or do you suspect that you may have prostate cancer? Then for friendly peer support and an introduction to Prospect email prospect.bristol@gmail.com or call the Tackle helpline, which will put you in touch with us:

0800 035 5302

This site has been compiled by prostate cancer survivors. We do not claim to have specialist knowledge other than that gained by prostate cancer patients during their treatment.

We give illustrated talks

Our Mike Broxton gives prostate cancer awareness talks to interested groups, including those with learning disabilities. To arrange a talk, contact prospect.bristol@gmail.com or 0800 035 5302.

Energise wins award

The exercise-based cancer rehab programme Energise won the Together We Achieve award for 2016. The award, announced at the inaugural Health & Care Awards in March, recognises teams working together to deliver improved patient care and public health. See a video about their work here. The classes are designed for people who have been affected by cancer and whose quality of life can be maintained or improved by taking part in regular, supervised exercise with cancer specialist instructors. Energise is a partnership between Macmillan, North Bristol NHS Trust, Sports Leisure Management Ltd and Bristol City Council. You can download a referral form at this site. In a Bristol Post article on the Easton scheme participants tell how it helped them improve mood, vitality and well-being, and to overcome cancer-related fatigue.

Regional co-ordinator needed

Tackle need a Regional Co-ordinator for Western Counties to replace Sandy Tyndale-Biscoe of Cornwall. The holder acts as a focal point for communications on region-specific topics between the chairman, Roger Wotton, and member groups in the area. See. In addition, he or she will participate in occasional meetings or teleconferences. If any Prospect member would like to volunteer for this rewarding role, they can email roger.wotton@tackleprostate.org All expenses are reimbursed. Tackle’s plans for regional meetings in 2016 will explore specific issues of regional/local interest and Prospect members’ views are welcome on what the preferred theme might be for the workshops.

New research strategy launched

Prostate Cancer UK has launched an ambitious 10-year strategy setting out how it will invest in the most innovative research to create a step change in our knowledge of prostate cancer. See. And we have more research news here.

Swedish test shows promise

Swedish researchers found that a test which involved genetic and protein biomarkers (the S3M) was much better than PSA alone at detecting potentially dangerous prostate cancers. The Swedish results give compelling evidence the S3M risk assessment model can dramatically cut the number of men undergoing unnecessary biopsies, without compromising their safety. But Prostate Cancer UK say it’s going to be important to validate this study in a more diverse population before they can accept that it will work elsewhere. See.

 

  • Know your risk

    Prostate Cancer UK has a new infographic and booklets.

    Treatment help

    www.myprostate.eu is now also available in English and prostate cancer patients can exchange information and help each other with treatment decisions.

  • Buddies support ends but…

    The Macmillan Skype Buddy service has closed. But you can still get help or advice from Macmillan by calling 0808 808 0000, Monday to Friday, 9am-8pm, or via their website.

  • Buddies offer home support

    This is a Macmillan service for Bristol, North Somerset and South Gloucestershire and offers support for adult cancer patients in people’s homes for up to 12 weeks. Ring 07543 248714 or email bristolbuddies@macmillan.org.uk